Form 4 for HUMA Humacyte, Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-13 · accession 0001818382-22-000224 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-19 | 2022-12-13 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | W - Inherited | $0.00 | +600 | 600 | New | $0 |
| I | 2022-12-19 | 2022-12-16 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | P - Purchase | $2.60 | +20.0K | 20.6K | +3,333% | +$52.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-13 | W | A | 600 | $0.00 | 600 | I By spouse | — | — | |
| 2 | Common | Common Stock | 2022-12-16 | P | A | 20,000 | $2.60 | 20,600 | I By spouse | — | — |